Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model ; volume:7 ; number:1 ; day:25 ; month:6 ; year:2014 ; pages:1-7 ; date:12.2014
BMC Research Notes / Biomed Central; 7, Heft 1 (25.6.2014), 1-7, 12.2014
- Urheber
-
Glaysher, Sharon
Bolton, Louise M.
Johnson, Penny
Torrance, Christopher
Cree, Ian A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-0500-7-397
- URN
-
urn:nbn:de:101:1-2021082521213122212934
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Glaysher, Sharon
- Bolton, Louise M.
- Johnson, Penny
- Torrance, Christopher
- Cree, Ian A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Profiling PI3K inhibitors with isogenic p110δ-dependent cells : impact of the binding pocket mutation I777M
EGFR and mTOR as therapeutic targets in glioblastoma
Identification of phytochemical as a dual inhibitor of PI3K and mTOR: a structure-based computational approach
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Die Wirkung von Inhibitoren des EGFR- und mTOR- Signalwegs auf kleinzellige Bronchialkarzinome und Chordome in vitro
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions
Deptor: not only a mTOR inhibitor
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Radiotherapy plus EGFR inhibitors: synergistic modalities
Matrix compression along isogenic blocks
Profiling PI3K inhibitors with isogenic p110δ-dependent cells : impact of the binding pocket mutation I777M
EGFR and mTOR as therapeutic targets in glioblastoma
Identification of phytochemical as a dual inhibitor of PI3K and mTOR: a structure-based computational approach
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Die Wirkung von Inhibitoren des EGFR- und mTOR- Signalwegs auf kleinzellige Bronchialkarzinome und Chordome in vitro
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions
Deptor: not only a mTOR inhibitor
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Radiotherapy plus EGFR inhibitors: synergistic modalities
Matrix compression along isogenic blocks
Profiling PI3K inhibitors with isogenic p110δ-dependent cells : impact of the binding pocket mutation I777M
EGFR and mTOR as therapeutic targets in glioblastoma
Identification of phytochemical as a dual inhibitor of PI3K and mTOR: a structure-based computational approach
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Die Wirkung von Inhibitoren des EGFR- und mTOR- Signalwegs auf kleinzellige Bronchialkarzinome und Chordome in vitro
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions
Deptor: not only a mTOR inhibitor
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Radiotherapy plus EGFR inhibitors: synergistic modalities